This groundbreaking perspective transforms our understanding of how Parkinson’s disease develops and progresses, opening new possibilities for prevention and treatment. In the past, Parkinson ...

These include, to name a few, a transformed understanding of Parkinson’s genetics, a crucial Parkinson’s biomarker discovered in 2023 and standing armies of clinical trial participants.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by 57% for every ...

“Over the past four years, ASAP's Collaborative Research Network has worked diligently to advance our understanding of Parkinson's disease (PD), focusing on functional genomics, neuro-immune ...

People with Parkinson’s disease are more likely to have received an ADHD diagnosis in the past compared with those who don’t have Parkinson’s. Several things may contribute to this link ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

This research isn’t just about finding a single solution to Parkinson’s disease – it’s part of a bigger shift in how we think about preventing neurological conditions. By understanding how ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify biomarkers of Parkinson’s disease well in advance of symptoms appearing.